Identification of Antitumor Lignans from the Seeds of Morning Glory (Pharbitis nil)
journal contributionposted on 06.08.2014, 00:00 by Ki Hyun Kim, Kyeong Wan Woo, Eunjung Moon, Sang Un Choi, Sun Yeou Kim, Sang Zin Choi, Mi Won Son, Kang Ro Lee
In the search for antitumor compounds from Korean natural resources, activity-guided fractionation and purification processes were used on seeds of morning glory (Pharbitis nil). Air-dried P. nil seeds were extracted with ethanol and separated into n-hexane, chloroform, ethyl acetate, and n-butanol. Four new lignans, pharbilignans A–D (1–4) were isolated from the most active ethyl acetate fraction of the ethanol extract. Their structures were characterized on the basis of spectroscopic methods, including one- and two-dimensional nuclear magnetic resonance (NMR) techniques, high resolution mass spectrometry (HRMS), and circular dichroism (CD) spectroscopy. The cytotoxic activities of the isolates (1–4) were evaluated by determining their inhibitory effects on four human tumor cell lines (A549, SK-OV-3, SK-MEL-2, and HCT15) using a sulforhodamine B (SRB) bioassay. Pharbilignan C (3) showed potent cytotoxicity against A549, SK-OV-3, SK-MEL-2, and HCT-15 cell lines with IC50 values of 1.42, 0.16, 0.20, and 0.14 μM, respectively. On the basis of the expanded understanding that inflammation is a crucial cause in tumor progress, we also evaluated anti-inflammatory activity of the isolates (1–4). Pharbilignan C (3) strongly inhibited nitric oxide (NO) production in the lipopolysaccharide (LPS)-activated BV-2 microglia cell line with an IC50 value of 12.8 μM.
Read the peer-reviewed publication
BVethyl acetate fractionAntitumor LignansIC 50 values12.8 μ MPharbilignan0.14 μ MHCTtumor cell linesethanolsulforhodamine Bnitric oxidebasisMorning GlorySRBethyl acetateNMRspectroscopic methodspurification processescytotoxic activitiesantitumor compoundsresolution mass spectrometrymorning gloryLPStumor progressIC 50 valueHRMSPharbiti